Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins

Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins

SARS-CoV-2 virus, the causative agent of COVID-19 pandemic, has a genomic organization consisting of 16 nonstructural proteins (nsps), 4 structural proteins, and 9 accessory proteins. Relative of SARS-CoV-2, SARS-CoV, has genomic organization, which is very similar. In this article, the function and...

Full description

Bibliographic Details
Main Authors:	Ritesh Gorkhali, Prashanna Koirala, Sadikshya Rijal, Ashmita Mainali, Adesh Baral, Hitesh Kumar Bhattarai
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-06-01
Series:	Bioinformatics and Biology Insights
Online Access:	https://doi.org/10.1177/11779322211025876

Similar Items

Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)
by: Azadeh Haghi Navand, et al.
Published: (2020-01-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)

Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA
by: Vipan Kumar Sohpal
Published: (2020-09-01)

Comparison between SARS-CoV and SARS-CoV 2
by: Fang Meng
Published: (2021-01-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2
by: Wenhan Guo, et al.
Published: (2021-04-01)

The emerging SARS-CoV, MERS-CoV, and SARS-CoV-2: An insight into the viruses zoonotic aspects
by: Karima A. Al-Salihi, et al.
Published: (2021-01-01)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
by: Yun-yu Zhang, et al.
Published: (2020-08-01)

Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
by: Yetian Dong, et al.
Published: (2020-10-01)

Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells
by: Susanna K.P. Lau, et al.
Published: (2020-12-01)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
by: Zeinab Abdelrahman, et al.
Published: (2020-09-01)

Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)
by: Francesco Sessa, et al.
Published: (2021-03-01)

Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species
by: Sultan Nafea Alharbi, et al.
Published: (2021-03-01)

Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV.
by: Priya V K, et al.
Published: (2021-01-01)

NeoCoV Is Closer to MERS-CoV than SARS-CoV
by: Mohamed M Hassan, et al.
Published: (2020-06-01)

H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection
by: Nan Zhou, et al.
Published: (2021-01-01)

H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection
by: Bao, J., et al.
Published: (2021)

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
by: Ma’mon M. Hatmal, et al.
Published: (2020-12-01)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.
by: Kwang Su Kim, et al.
Published: (2021-03-01)

Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico
by: Mitsuru Sada, et al.
Published: (2020-10-01)

Trends in MERS-CoV, SARS-CoV, and SARS-CoV-2 (COVID-19) Diagnosis Strategies: A Patent Review
by: José Adão Carvalho Nascimento Junior, et al.
Published: (2020-10-01)

Convalescent plasma as a therapeutic agent for SARS-CoV, MERS-CoV and SARS-CoV-2: A scoping review
by: Abeba Haile Mariamenatu, et al.
Published: (2021-01-01)

Prefusion spike protein conformational changes are slower in SARS-CoV-2 than in SARS-CoV-1
by: Isu, U.H, et al.
Published: (2022)

Comparison of Selected Characteristics of SARS-CoV-2, SARS-CoV, and HCoV-NL63
by: Darina Bačenková, et al.
Published: (2021-02-01)

Reviewing immunopathology characteristics of SARS-CoV-2 for cancer entwisted with SARS-CoV-2
by: Hongyan Li, et al.
Published: (2021-01-01)

The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2
by: Ahmed M. Alluwaimi, et al.
Published: (2020-09-01)

Investiagation of possible mechanism of eye transmission of SARS-CoV-2 based on SARS-CoV
by: Fu-Lai Niu<sup>*</sup>, et al.
Published: (2020-04-01)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
by: Yong Xia, et al.
Published: (2020-07-01)

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
by: Huibin Lv, et al.
Published: (2020-06-01)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
by: Kuldeep Singh Patel, et al.
Published: (2020-03-01)

The RNA Architecture of the SARS-CoV-2 3′-Untranslated Region
by: Junxing Zhao, et al.
Published: (2020-12-01)

Lack of Susceptibility to SARS-CoV-2 and MERS-CoV in Poultry
by: David L. Suarez, et al.
Published: (2020-12-01)

Dataset of mutational analysis, miRNAs targeting SARS-CoV-2 genes and host gene expression in SARS-CoV and SARS-CoV-2 infections
by: Rahila Sardar, et al.
Published: (2020-10-01)

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
by: Yanwen Liang, et al.
Published: (2020-05-01)

SARS‐CoV‐2 and hypertension
by: Briyanth Ravichandran, et al.
Published: (2021-06-01)

SARS-CoV-2: is there neuroinvasion?
by: Conor McQuaid, et al.
Published: (2021-07-01)

Neutralizing SARS-CoV-2
by: Eric Poeschla
Published: (2020-12-01)

SARS-CoV-2 in humans
by: Marco Binder, et al.
Published: (2021-04-01)

Koronavirus SARS-CoV-2
by: Ksenija Geršak, MD, PhD
Published: (2020-04-01)

Characterization of SARS-CoV accessory proteins
by: Freundt, Eric C.
Published: (2007)